These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6396563)
1. [Aggressive chemotherapy in generalized eosinophilic granuloma in adults]. Görg C; Görg K; Gropp C; Havemann K Onkologie; 1984 Dec; 7(6):360-2. PubMed ID: 6396563 [TBL] [Abstract][Full Text] [Related]
2. [Treatment problems of eosinophilic granuloma]. Kowalewska B; Gałazka Z Pol Merkur Lekarski; 1998 Mar; 4(21):164-5. PubMed ID: 9640072 [TBL] [Abstract][Full Text] [Related]
3. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. Tulpule A; Espina BM; Berman N; Buchanan LH; Smith DL; Sherrod A; Dharmapala D; Gee C; Boswell WD; Nathwani BN; Welles L; Levine AM Clin Lymphoma Myeloma; 2006 Jul; 7(1):59-64. PubMed ID: 16879771 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of cytophagic histiocytic panniculitis with modified CHOP-E. Cyclophosphamide, adriamycin, vincristine, predonisone, and etoposide. Matsue K; Itoh M; Tsukuda K; Miyazaki K; Kokubo T Am J Clin Oncol; 1994 Dec; 17(6):470-4. PubMed ID: 7977162 [TBL] [Abstract][Full Text] [Related]
5. Spinal cord compression by a unifocal eosinophilic granuloma: a case report of an adult with unusual roentgenological features. Kanterewicz E; Condom E; Cañete JD; Del Olmo JA Neurosurgery; 1988 Nov; 23(5):666-8. PubMed ID: 3200402 [TBL] [Abstract][Full Text] [Related]
6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
7. Large B-cell non-Hodgkin lymphoma. Vaseemuddin M; Sam R Am J Kidney Dis; 2005 Dec; 46(6):A52, e101-2. PubMed ID: 16315353 [No Abstract] [Full Text] [Related]
8. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007). Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021 [TBL] [Abstract][Full Text] [Related]
10. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082 [TBL] [Abstract][Full Text] [Related]
11. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma. Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B; Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635 [TBL] [Abstract][Full Text] [Related]
12. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia. Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691 [TBL] [Abstract][Full Text] [Related]
13. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature. Alduaij A; Butera JN; Treaba D; Castillo J Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):480-3. PubMed ID: 21156467 [TBL] [Abstract][Full Text] [Related]
14. Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study. Tsurumi H; Yamada T; Sawada M; Kasahara S; Kanemura N; Kojima Y; Fukuno K; Hara T; Saio M; Takahashi T; Oyama M; Ozawa K; Takami T; Moriwaki H J Cancer Res Clin Oncol; 2004 Feb; 130(2):107-13. PubMed ID: 14648210 [TBL] [Abstract][Full Text] [Related]
15. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma]. Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532 [No Abstract] [Full Text] [Related]
16. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma. Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727 [TBL] [Abstract][Full Text] [Related]
17. Thoracic rib solitary eosinophilic granuloma in a child. Zhang KR; Ji SJ; Zhang LJ; Li XY J Pediatr Orthop B; 2009 May; 18(3):148-50. PubMed ID: 19391248 [TBL] [Abstract][Full Text] [Related]
18. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck. Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202 [TBL] [Abstract][Full Text] [Related]
19. Advances in chemotherapy for large cell lymphoma. Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781 [TBL] [Abstract][Full Text] [Related]
20. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients. Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]